APA (7th ed.) Citation

Huang, L., Jiang, S., & Shi, Y. (2020). Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020). Journal of Hematology & Oncology, 13(1), 1. https://doi.org/10.1186/s13045-020-00977-0

Chicago Style (17th ed.) Citation

Huang, Liling, Shiyu Jiang, and Yuankai Shi. "Tyrosine Kinase Inhibitors for Solid Tumors in the Past 20 Years (2001–2020)." Journal of Hematology & Oncology 13, no. 1 (2020): 1. https://doi.org/10.1186/s13045-020-00977-0.

MLA (9th ed.) Citation

Huang, Liling, et al. "Tyrosine Kinase Inhibitors for Solid Tumors in the Past 20 Years (2001–2020)." Journal of Hematology & Oncology, vol. 13, no. 1, 2020, p. 1, https://doi.org/10.1186/s13045-020-00977-0.